ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 170 filers reported holding ASCENDIS PHARMA A/S in Q3 2021. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $315,000 | -35.7% | 3,391 | -18.8% | 0.14% | -59.1% |
| Q1 2022 | $490,000 | +2.3% | 4,178 | +17.4% | 0.35% | -61.7% |
| Q4 2021 | $479,000 | -12.9% | 3,560 | +3.2% | 0.91% | +24.5% |
| Q3 2021 | $550,000 | +17.0% | 3,451 | -5.3% | 0.73% | +58.9% |
| Q1 2021 | $470,000 | +3.8% | 3,646 | +34.2% | 0.46% | -4.3% |
| Q4 2020 | $453,000 | -46.5% | 2,717 | -50.5% | 0.48% | +9.3% |
| Q3 2020 | $847,000 | +34.0% | 5,486 | +28.3% | 0.44% | +4.5% |
| Q2 2020 | $632,000 | +62.5% | 4,276 | +23.7% | 0.42% | +44.4% |
| Q1 2020 | $389,000 | -47.8% | 3,458 | -35.4% | 0.29% | -28.9% |
| Q4 2019 | $745,000 | +66.3% | 5,357 | +37.7% | 0.41% | +34.2% |
| Q2 2019 | $448,000 | – | 3,891 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |